Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Why Are People Selling Their AFRM Shares?

After this afternoon's -9.1% drop to $71.81 per share, Affirm might just keep moving past its target price of $73.66. With an average analyst rating of buy, and target prices from $56.0 to $90.0, the stock's next move is anyone's guess.

The stock has an average amount of shares sold short at 5.6%, and a short ratio of 2.69. The company's insiders own 4.67% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that an average number of institutional investors are invested in the stock, with 80.0% of Affirm's shares being owned by this investor type.

Institutions Invested in Affirm

Date Reported Holder Percentage Shares Value
2025-03-31 Vanguard Group Inc 8% 23,272,997 $1,671,233,857
2025-03-31 Capital Research Global Investors 8% 23,124,260 $1,660,553,054
2025-03-31 Morgan Stanley 8% 21,196,218 $1,522,100,362
2025-03-31 Capital World Investors 7% 20,218,782 $1,451,910,686
2025-03-31 Blackrock Inc. 5% 13,218,366 $949,210,830
2025-03-31 FMR, LLC 3% 8,424,010 $604,928,137
2025-06-30 BAILLIE GIFFORD & CO 3% 7,532,410 $540,902,343
2025-03-31 Durable Capital Partners Lp 2% 6,580,882 $472,573,120
2025-03-31 Jericho Capital Asset Management, LP 2% 5,057,039 $363,145,958
2025-03-31 Price (T.Rowe) Associates Inc 2% 4,544,132 $326,314,107

Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on Affirm.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS